Yüklüyor......
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
Presently, we need more therapeutic molecules for this COVID-19 outbreak. The severity and mortality of the disease is associated with a high level of release of cytokine in the patients which is known as CRS (cytokine release syndrome) or cytokine storm syndrome. IL-6 is a type of pro-inflammatory...
Kaydedildi:
| Yayımlandı: | Arch Med Res |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
IMSS. Published by Elsevier Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7241374/ https://ncbi.nlm.nih.gov/pubmed/32482373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.arcmed.2020.05.009 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|